Show simple item record

dc.contributor.authorLan, C
dc.contributor.authorLi, J
dc.contributor.authorHuang, X
dc.contributor.authorHeindl, A
dc.contributor.authorWang, Y
dc.contributor.authorYan, S
dc.contributor.authorYuan, Y
dc.date.accessioned2020-06-11T12:18:02Z
dc.date.issued2019-02-18
dc.identifier.citationBMC cancer, 2019, 19 (1), pp. 159 - ?
dc.identifier.issn1471-2407
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3720
dc.identifier.eissn1471-2407
dc.identifier.doi10.1186/s12885-019-5343-8
dc.description.abstractBACKGROUND: Identifying high-risk patients for platinum resistance is critical for improving clinical management of ovarian cancer. We aimed to use automated image analysis of hematoxylin & eosin (H&E) stained sections to identify the association between microenvironmental composition and platinum-resistant recurrent ovarian cancer. METHODS: Ninety-one patients with ovarian cancer containing the data of automated image analysis for H&E histological sections were initially reviewed. RESULTS: Seventy-one patients with recurrent disease were finally identified. Among 30 patients with high stromal cell ratio, 60% of the patients had platinum-resistant recurrence, which was significantly higher than the rate in patients with low stromal cell ratio (9.80%, P <  0.001). Multivariate logistic regression analysis revealed elevated CA125 level after 3 cycles of chemotherapy (P <  0.001) and high stromal cell ratio (P = 0.002) were the negative predictors of platinum-resistant relapse. The area under the curve (AUC) of receiver operating characteristic (ROC) curves of the models for predicting platinum-resistant recurrence with stromal cell ratio, normalization of CA125 level, and the combination of two parameters were 0.78, 0.79, and 0.89 respectively. CONCLUSIONS: Our results demonstrated stromal cell ratio based on automated image analysis may be a potential predictor for ovarian cancer patients at high risk of platinum-resistant recurrence, and it could improve the predictive value of model when combined with normalization of CA125 level after 3 cycles of chemotherapy.
dc.formatElectronic
dc.format.extent159 - ?
dc.languageeng
dc.language.isoeng
dc.publisherBMC
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectStromal Cells
dc.subjectHumans
dc.subjectOvarian Neoplasms
dc.subjectNeoplasm Recurrence, Local
dc.subjectPlatinum
dc.subjectMembrane Proteins
dc.subjectCA-125 Antigen
dc.subjectDrug Therapy
dc.subjectLogistic Models
dc.subjectOdds Ratio
dc.subjectChi-Square Distribution
dc.subjectDrug Resistance, Neoplasm
dc.subjectImage Processing, Computer-Assisted
dc.subjectAged
dc.subjectFemale
dc.subjectTumor Microenvironment
dc.subjectBiomarkers, Tumor
dc.titleStromal cell ratio based on automated image analysis as a predictor for platinum-resistant recurrent ovarian cancer.
dc.typeJournal Article
dcterms.dateAccepted2019-02-01
rioxxterms.versionofrecord10.1186/s12885-019-5343-8
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2019-02-18
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBMC cancer
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Computational Pathology & Integrated Genomics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Computational Pathology & Integrated Genomics
pubs.publication-statusPublished
pubs.volume19
pubs.embargo.termsNot known
icr.researchteamComputational Pathology & Integrated Genomics
dc.contributor.icrauthorYuan, Yinyin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0